135 related articles for article (PubMed ID: 1315241)
1. Production of human monoclonal antibodies: potential therapeutic use in gut-derived infectious-toxic shock syndromes.
Waelti ER; Stucki M
Curr Stud Hematol Blood Transfus; 1992; (59):324-47. PubMed ID: 1315241
[No Abstract] [Full Text] [Related]
2. Possibilities of immunoprophylaxis and immunotherapy in gut-derived infectious-toxic shock (GITS).
Imbach P; Hässig A; Cottier H
Curr Stud Hematol Blood Transfus; 1992; (59):301-23. PubMed ID: 1572217
[No Abstract] [Full Text] [Related]
3. Novel approaches to the preparation and use of monoclonal antibodies.
Lemieux R; Bazin R
Transfus Med Rev; 1993 Jan; 7(1):25-36. PubMed ID: 8381687
[No Abstract] [Full Text] [Related]
4. [Cytokines and septic shock. New perspectives on its treatment].
Zamora Madaria E
An Med Interna; 1993 Dec; 10(12):573-5. PubMed ID: 8049320
[No Abstract] [Full Text] [Related]
5. Immunological intervention in endotoxin shock.
Ziegler EJ
Prog Clin Biol Res; 1988; 272():319-25. PubMed ID: 3293079
[No Abstract] [Full Text] [Related]
6. Monoclonal antibodies: technology and application to gram-negative infections.
Young LS
Infection; 1984; 12(4):303-8. PubMed ID: 6208152
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies and the treatment of gram-negative bacteremia and shock.
Wolff SM
N Engl J Med; 1991 Feb; 324(7):486-8. PubMed ID: 1988835
[No Abstract] [Full Text] [Related]
8. [Production and characterization of monoclonal antibodies directed agains the major outer membrane protein and lipopolysaccharide of Chlamydia trachomatis].
Cuffini C; Becher S; Adamo P; Pedranti M; Zapata M
Rev Argent Microbiol; 2001; 33(4):203-8. PubMed ID: 11833251
[TBL] [Abstract][Full Text] [Related]
9. Selection of new heteromyeloma cell lines for the obtainment of human monoclonal antibodies.
Zanella I; Verardi R; Negrini R; Osio L; Albertini A; Ghielmi S
Year Immunol; 1993; 7():213-9. PubMed ID: 8396821
[No Abstract] [Full Text] [Related]
10. Antibody to endotoxin in the treatment of gram-negative sepsis.
McCabe WR
JAMA; 1992 May; 267(17):2325; author reply 2326. PubMed ID: 1564763
[No Abstract] [Full Text] [Related]
11. Generation of monoclonal antibodies against surface antigens of Moraxella bovis.
Aleixo JA; Barbosa RC; Gil-Turnes C
Hybridoma; 1991 Oct; 10(5):625-31. PubMed ID: 1804773
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic effects of endotoxin.
Zivot JB; Hoffman WD
New Horiz; 1995 May; 3(2):267-75. PubMed ID: 7583168
[TBL] [Abstract][Full Text] [Related]
13. Antibody engineering, a strategy for the development of monoclonal antibodies.
Schönherr OT; Houwink EH
Antonie Van Leeuwenhoek; 1984; 50(5-6):597-623. PubMed ID: 6099095
[TBL] [Abstract][Full Text] [Related]
14. Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization.
Lang AB; Fürer E; Senyk G; Larrick JW; Cryz SJ
Hum Antibodies Hybridomas; 1990; 1(2):96-103. PubMed ID: 2129420
[TBL] [Abstract][Full Text] [Related]
15. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
Calandra T; Baumgartner JD; Glauser MP
Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
[TBL] [Abstract][Full Text] [Related]
16. Production and characterisation of mouse monoclonal antibodies reacting with the lipopolysaccharide core region of gram-negative bacilli.
Appelmelk BJ; Verweij-van Vught AM; Maaskant JJ; Schouten WF; De Jonge AJ; Thijs LG; Maclaren DM
J Med Microbiol; 1988 Jun; 26(2):107-14. PubMed ID: 2455054
[TBL] [Abstract][Full Text] [Related]
17. Human lymphocyte hybridomas and monoclonal antibodies.
Carson DA; Freimark BD
Adv Immunol; 1986; 38():275-311. PubMed ID: 3008522
[No Abstract] [Full Text] [Related]
18. [Monoclonal antibodies in the treatment of septic shock].
Trilla A; Alonso P
Med Clin (Barc); 1992 Dec; 99(20):778-80. PubMed ID: 1460950
[No Abstract] [Full Text] [Related]
19. Antibody to endotoxin in the treatment of gram-negative sepsis.
van Deventer S
JAMA; 1992 May; 267(17):2325-6. PubMed ID: 1564765
[No Abstract] [Full Text] [Related]
20. Recent developments in our understanding of sepsis: evaluation of anti-endotoxin antibodies and biological response modifiers.
Talan DA
Ann Emerg Med; 1993 Dec; 22(12):1871-90. PubMed ID: 8239111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
